Resources search

Health South Africa : efforts to ARV for kids are still in their infancy

NDURU, Moyiga
May 2004

Expand view

An interesting article noting the challenges of supplying the medicines to HIV positive children who have received little attention. Early in 2004 the South African national programme to provide anti-retrovirals (ARVs) became operational. There is now hope that this will bring opportunities for under 14 year olds including very young children to gain more access to the drugs. The government is seeking to treat over 50,000 people per year under the ARV programme. In private clinics it costs almost US$93 to put a child on ARV for one month although this has halved since two years ago. Doctors and health officials are debating about what age is right for a child to start ARV treatment although theoretically it can start as soon as it is born. Doctors Without Borders advises that treatment should start as soon as a child is discovered to be HIV positive so that the immune system is bolstered

Equitable access to essential medicines : a framework for collective action

WORLD HEALTH ORGANIZATION (WHO)
March 2004

Expand view

Equitable and universal access to essential medicines is a vital aspect of any health strategy in resource-limited settings. This document provides a framework of action for policy makers, highlighting the key objectives of successful essential drugs programmes: rational selection and use of essential medicines; affordable prices; sustainable financing; reliable supply systems

Health systems strengthening and HIV/AIDS : an annotated bibliography and resources

KOLYADA, Lena
March 2004

Expand view

This annotated bibliography has been prepared in an effort to provide policy makers, technical personnel and other stakeholders with comprehensive information on the costs of interventions and impact of HIV on health systems. The documents included in the bibliograpy focus on those aspects of the pandemic most related to economic impact, financing and resource allocation, costing, health system strengthening, scaling up antiretroviral therapy, surveillance systems, and programme monitoring and evaluation. The bibliography describes 101 publications describing work done from 1995 onwards as well as a directory of web resources. The bibliography is not a comprehensive reveiw, but is rather intended to highlight current information in the field of HIV and health systems strengthening

Improving the health of the world's poorest people [whole issue]

CARR, Dara
2004

Expand view

This bulletin examines the facets of the rich-poor health divide, factors that play a role in in health disaparities, and approaches for improving the health of the poor (socio-economic health service and health financing). It also provides indicators for monitoring progress to diminishing the disparities. In recent years a great deal of research has become available on health inequalities within low-income countries. This report provides the latest data on how the world's poorest people are faring on key indicators of reproductive and child health

The world medicines situation

WORLD HEALTH ORGANIZATION (WHO)
2004

Expand view

The publication provides an accessible source of information on the pharmaceutical situation at global and national levels. It assembles the available evidence regarding the production and consumption of medicines, and a range of issues in national medicines policies, including the level of people's access, patterns of use, the challenges of medicines regulation and promoting rational use. Numerous different sources of data are used. A 32-page annex of statistics is included. The target readers are researchers, academics and analysts concerned with medicines and public health

Global tuberculosis control : surveillance, planning, financing. WHO Report 2004

WORLD HEALTH ORGANIZATION (WHO)
2004

Expand view

This is the 8th WHO annual report on global TB control. Provides a comprehensive overview of national TB control programmes and an analysis of plans and expenditures. It also details progress and the state of implementation of the internationally recommended control strategy for TB (DOTS). Total estimated costs for high-burden countries amounted to approximately US$ 1 billion, with an overall funding gap of US$ 41 million in 2003. However, the case detection rate is expected to be about 50% by 2005, a clear improvement on 2002 rates

Health care systems in transition : Estonia

JESSE, Maris
EUROPEAN OBSERVATORY ON HEALTH SYSTEMS AND POLICIES
2004

Expand view

"The Health Care Systems in Transition (HiT) profiles are country-based reports that provide an analytical description of a health care system and of reform initiatives in progress or under development. The HiTs are a key element of the work of the European Observatory on Health Systems and Policies. HiTs seek to provide relevant comparative information to support policy-makers and analysts in the development of health care systems in Europe." Contents: 1. Introduction and historical background 2. Organizational structure and management 3. Health care financing and expenditure 4. Health care delivery system 5. Financial resource allocation 6. Health care reforms

Ghana national drug policy

Ministry of Health, Ghana
2004

Expand view

This policy includes the following sections: a situational analysis of drug selection; drug procurement, storage and distribution; drug financing; quality assurance; local manufacture of pharmaceutical and traditional medicinal products; rational drug use; global trade and pharmaceuticals; emerging diseases and pharmaceuticals; human resource development for drug management; traditional medicinal products; research and development; and implementation of the policy

Robbing the poor to pay the rich? How the United States keeps medicines from the world's poorest

BRANT, Jennifer
November 2003

Expand view

This paper examines how the government of the United States is contravening its commitment to the World Trade Organisation's Doha Declaration (to prioritize public health over private patent rights and to promote access to medicines) by using technical assistance, bilateral and regional trade agreements, and the threat of trade sanctions to ratchet up patent protection in developing countries. This policy benefits the influential US pharmaceutical industry while pushing medicines further out of the reach of poor people

Impact of public-private partnerships addressing access to pharmaceuticals in low income countries : Uganda pilot study

CAINES, Karen
et al
October 2003

Expand view

This is the report of a pilot study in Uganda to assess the health and health systems impact of public-private partnerships (PPPs) for improving access to pharmaceuticals in relation to leprosy, lymphatic filariasis, onchocerciasis, sleeping sickness, and HIV and AIDS. It examines issues of ownership, integration, coordination, implementation and impact, with a particular focus on the unique strengths and problems of these access PPPs as distinct from other comparable programmes where drugs are competitively procured

Efficiency in reaching the millennium development goals

JAYASURIYA, Ruwan
WODON, Quentin
June 2003

Expand view

This study deals with the MDG-related topic of increasing the efficiency of countries in producing good outcomes with their available resources. The first two papers use country-level data to look at the efficiency of countries in improving health, education, and GDP outcomes. The last two use within-country data on health and education in Argentina and Mexico to look at the same issues. The analysis helps quantify how much progress could be achieved through better efficiency, and to some extent, how efficiency itself could be improved

Act now to get malaria treament that works to Africa

COX, Ingrid
HAKAGONGAS, Laura
MAYBAUM, Jennifer
April 2003

Expand view

This report calls on international donors to join with African countries in implemeting World Health Organization (WHO) guidelines on the treatment of malaria. WHO recommends that African countries facing resistance to classical antimalarials introduce drug combinations containing artemisinin derivatives - artemisinin-based combination therapy (ACT). This report defines the malaria problem, looks at what works in malaria treatment and outlines what needs to be done to make ACT work in reality

Medicine prices : a new approach to measurement

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
2003

Expand view

This manual describes a new approach to measuring the prices people have to pay for a selection of important medicines in different medicine outlets. The manual also describes how to collect information on price composition (taxes, mark-ups, fees) and assess the affordability and availability of medicines

The Africa malaria report

WORLD HEALTH ORGANIZATION (WHO)
UNITED NATIONS CHILDREN'S FUND (UNICEF)
2003

Expand view

This report takes stock of the malaria situation and of continuing efforts to tackle the disease in Africa

Guidelines for price discounts of single-source pharmaceuticals

WORLD HEALTH ORGANIZATION (WHO). Essential Drugs and Medicines Policy
et al
2003

Expand view

These guidelines are designed to maximise the benefit of price discounts arrangements for single-source products. They are intended for policy makers and technical staff in international and bilateral agencies active in international health development support, for pharmaeutical companies and for governments and NGOs in recipient countries. It highlights a number of issues that WHO feels need to be considered when planning or negotiating offers of price discounts

Poverty, equity, human rights and health

BRAVEMAN, Paula
GRUSKIN, Sofia
2003

Expand view

Those concerned with poverty and health have sometimes viewed equity and human rights as abstract concepts with little practical application, and links between health, equity and human rights have not been examined systematically. This article outlines five ways in which health institutions can deal with poverty and health: institutionalising the systematic and routine application of equity and human rights perspectives to all health sector actions; strengthening and extending the public health functions that create the conditions necessary for health; implementing equitable health care financing, which should reduce poverty while increasing access for the poor; ensuring that health services respond effectively to the major causes of preventable ill-health among the poor and disavantaged; and monitoring, advocating and taking action to address the potential health equity and human rights implications of policies in all sectors affecting health, not only the health sector

IPR, innovation, human rights and access to drugs : an annotated bibliography

VELASQUEZ, Germán
VIDAL, Jaume
2003

Expand view

This annotated bibliography brings together references to scientific, legal and other materials on globalisation, patents and drugs. It is organised into sections on general articles (basic literature on the topic), country studies (by region), thematic sections on TRIPS (the World Trade Organization treaty on patents) and patents, drug research and development, and human rights and access to drugs. Finally a section on electronic information sources highlights useful websites and discussion groups on these issues. Each reference includes full bibliographic information and a thorough, descriptive abstract detailing the key points of each item

Pages

E-bulletin